RCA
ZOM

Reitz Capital Advisors’s Zomedica Corp. ZOM Stock Holding History

Reitz Capital Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$4.61K Hold
23,000
– – 0.01% 22
2023
Q4 		$4.61K Hold
23,000
– – 0.01% 24
2023
Q3 		$3.88K Hold
23,000
– – 0.01% 45
2023
Q2 		$4.6K Hold
23,000
– – ﹤0.01% 47
2023
Q1 		$4.87K Hold
23,000
– – ﹤0.01% 52
2022
Q4 		$4K Buy
23,000
+500
+2% +$102 ﹤0.01% 49
2022
Q3 		$5K Buy
22,500
+7,500
+50% +$1.99K ﹤0.01% 47
2022
Q2 		$3K Hold
15,000
– – ﹤0.01% 53
2022
Q1 		$5K Sell
15,000
-450
-3% -$147 ﹤0.01% 76
2021
Q4 		$13K Buy
15,450
+2,050
+15% +$923 0.01% 49
2021
Q3 		$7K Sell
13,400
-2,050
-13% -$1.21K 0.01% 47
2021
Q2 		$13K Buy
+15,450
New +$14.4K 0.01% 49

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return